ArticleIranian journal of veterinary research2024
Effects of major OMPs and LPS of
Article in Iranian journal of veterinary research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Mapping the research landscape of immune response in human brucellosis: a bibliometric analysis.Frontiers in microbiology · 2025Pooled it
- Application of Outer Membrane Protein Omp25 in Serological Diagnosis of Brucellosis.Infectious disease reports · 2026Review
- Spatiotemporal dynamics of Brucella immune evasion across infection stages.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Aims: To investigate the effects of Methods: BMDC were isolated and cultured Results: The impact of LPS on BMDC maturation, TLRs-mediated cytokine secretion, and antigen presentation was found to be limited. In contrast, rOMP10, rOMP19, and rBP26 were observed to promote BMDC maturation, increase the expression of TLR-2 and TLR-4 mRNA, and activate T-lymphocyte proliferation by significantly increasing the expression of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-6, IL-12) and antigen-presenting molecules. However, rOMP25 and rOMP31 did not promote BMDC maturation, inhibited the expression of MHCI and MHCII antigen-presenting molecules, and increased the expression of inflammation-suppressing cytokines (IL-10 and IL-4), resulting in the inhibition of T-lymphocyte proliferation. Conclusion:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.